The CAG repeat polymorphism in the Androgen receptor gene modifies the risk for hypospadias in Caucasians by Tatjana Adamovic & Agneta Nordenskjöld
Adamovic and Nordenskjöld BMC Medical Genetics 2012, 13:109
http://www.biomedcentral.com/1471-2350/13/109RESEARCH ARTICLE Open AccessThe CAG repeat polymorphism in the Androgen
receptor gene modifies the risk for hypospadias in
Caucasians
Tatjana Adamovic1* and Agneta Nordenskjöld1,2*Abstract
Background: Hypospadias is a birth defect of the urethra in males, and a milder form of 46,XY disorder of sexual
development (DSD). The disease is characterized by a ventrally placed urinary opening due to a premature fetal
arrest of the urethra development. Moreover, the Androgen receptor (AR) gene has an essential role in the
hormone-dependent stage of sexual development. In addition, longer AR polyglutamine repeat lengths encoded
by CAG repeats are associated with lower transcriptional activity in vitro. In the present study, we aimed at
investigating the role of the CAG repeat length in the AR gene in hypospadias cases as compared to the controls.
Our study included 211 hypospadias and 208 controls of Caucasian origin.
Methods: We amplified the CAG repeat region with PCR, and calculated the difference in the mean CAG repeat
length between the hypospadias and control group using the T-test for independent groups.
Results: We detected a significant increase of the CAG repeat length in the hypospadias cases when compared to
the controls (contrast estimate: 2.29, 95% Confidence Interval (1.73-2.84); p-value: 0.001). In addition, the odds ratios
between the hypospadias and controls revealed that the hypospadias cases are two to 3 times as likely to have
longer CAG repeats than a shorter length for each repeat length investigated.
Conclusions: We have investigated the largest number of hypospadias cases with regards to the CAG repeat
length, and we provide evidence that a higher number of the CAG repeat sequence in the AR gene have a clear
effect on the risk of hypospadias in Caucasians.
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The Androgen receptor (AR) gene is located on chromo-
some Xq12 and is involved in the generation of the male
internal and external genitalia through the actions of tes-
tosterone and 5α-dihydrotestosterone (DHT) [1]. The
product of this gene belongs to the nuclear receptor
class, and is expressed in the developing human penis
and urethra [2]. It affects the expression of androgen
regulated genes critical for the development of the male
sexual phenotype by recognizing the canonical androgen
response elements (AREs) in the DNA once it has* Correspondence: tatjana.adamovic@hotmail.com; agneta.nordenskjold@ki.se
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distribution, and reproduction in any mediumformed a complex with DHT or testosterone in the cyto-
plasm [3].
Mutations in the AR gene that severely impact the func-
tion of the receptor can cause the syndrome of partial or
complete androgen insensitivity, and have also been
observed in a few cases of isolated hypospadias [4-10].
The malformation of hypospadias is described as a birth
defect of the urethra in males, and is considered to be a
milder form of 46,XY disorder of sex development (DSD).
It is characterized by a ventrally placed urinary opening in
boys and affects 3 per 1000 males in Sweden since the
beginning of the 1970s (data from the annual Swedish
Malformation Registry). This disease is influenced both by
genes and environmental factors, and about 10 % of these
boys have a family history of hypospadias. Most cases with
hypospadias are reported to be sporadic [11].BioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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examination of the newborns, with subsequent surgery
in their first two years of life. Still, the molecular
mechanisms behind this disease, particularly in the spor-
adic form, are largely unknown.
Since AR mediates important biological effect of tes-
tosterone and DHT, it is an obvious candidate in the de-
velopment of hypospadias. Moreover, greater number of
CAG repeats within the AR gene results in longer poly-
glutamine tracts in the AR, and cause the AR to have a
reduced transcriptional activity and to associate with
moderate to severe undermasculinized genitalia in XY
males [12]. In addition, we previously performed a study
in which we [13], and another independent group [14],
assessed the CAG repeat length in a small number of
cases with hypospadias. However, no association was
found between the CAG repeat length and the investi-
gated cases when compared to the controls. In the
present study, we decided to investigate possible associ-
ation of the CAG repeat length in the AR gene with the
disease of hypospadias in a significantly larger patient
material.
Results
The CAG repeat length in cases with hypospadias and in
controls
We compared the number of CAG repeats in the AR
gene in each case from the hypospadias group with the
repeats in individuals from the control group. We first
calculated the skewness for each group, and detected the
CAG repeats to be normally distributed within each
group (see Table 1; mean and median length are also
presented). We next used the T-test for independent
groups, and found a clear statistical difference in the
mean CAG repeat length between the control and hypo-
spadias group (p<0.001). Thus, the estimated mean CAG
repeat length difference was calculated to 2.29 (CI, 1.73-
2.84). We further detected a significant difference in the
median CAG repeat length between the two groups
using the Chi-square test (p<0.001). Figure 1 illustrates
the distribution of the repeats, and clearly shows a
greater frequency of the longer repeat tracts in the hypo-
spadias group.
Moreover, Odds Ratio (OR) was calculated between
the hypospadias and the control group for a range of re-
peat sizes using logistic regression (see Table 2). ATable 1 Mean and median CAG repeat length in the hypospa
Hypospadias Cases (n) Mean Median Minimum M
Nr. of CAG repeats 211 20.07 19.87 13.13 3
Controls Controls (n) Mean Median Minimum M
Nr. of CAG repeats 208 17.78 17.78 11.00 2
Abbreviations: SD, standard deviationsignificant OR was detected for each repeat size investi-
gated (Table 2).
Discussion
In the present investigation, we detected a significantly
expanded CAG repeat length located in exon 1 of the
AR gene in the largest number of examined Caucasian
patients with hypospadias reported so far. Thus, our
findings suggest a role of the CAG repeat polymorphism
in the development of hypospadias.
Several pathways have up until now been implicated in
male urethra development, and the strong focus of gen-
etic research on the hormone-dependent stage of sexual
development has revealed promising candidate genes,
among which the AR gene is included. Expansion of the
CAG repeat length in exon 1 has previously been
reported to decrease AR transactivation function [15].
An even larger increase in the number of CAG repeats
in the AR gene has further been detected in the rare X-
linked neurodegenerative disorder, spinal and bulbar
muscular atrophy (SBMA), or Kennedy’s disease [16],
where the expanded repeats varied between 40–62, com-
pared to 11–31, as seen in healthy individuals [17,18]. It
has also been reported that other polymorphisms, such
as longer GGN repeat lengths in the AR, increase the
risk for penile hypospadias [13,19]. These latter reports,
which include our previously published data [13], were
not able to detect any association between the CAG re-
peat length and the disease of hypospadias, which may
be due to the small sample size investigated. In our
present study, we describe the investigation of a much
larger patient material, in which we detect a significant
difference of the CAG repeat length in the cases, yield-
ing a markedly increased sequence length. Thus, the
magnitude of the difference in mean CAG repeat length
was estimated to 2.29. Moreover, the calculated ORs be-
tween the hypospadias cases and controls revealed that
the hypospadias cases are two to 3 times as likely to have
longer CAG repeats than a shorter length for each re-
peat length investigated. Hence, the event may cause a
decrease in the AR transactivation function, as previ-
ously reported [12,15].
Conclusions
Our analysis suggests a role of expanded CAG repeat
length in the development of hypospadias. Based on ourdias and control group
aximum Lower quartile Upper quartile SD Skewness
2.07 18.22 21.73 2.76 0.56
aximum Lower quartile Upper quartile SD Skewness
9.77 15.62 19.41 3.00 0.76
Figure 1 Distribution of CAG repeat sizes in exon 1 of the AR gene in controls and in cases with hypospadias.
Table 2 Odds Ratio (OR) analysis of the CAG repeat
length in the hypospadias group as compared to the
controls
CAG nr. Control % Hypospadias % OR 95% CI
≤18 52.40 21.33
≥18 48.56 78.67 3.91* 2.55-5.99
≥19 34.62 61.61 3.03* 2.03-4.51
≥20 21.63 48.82 3.45* 2.25-5.29
≥21 12.50 36.02 3.94* 2.39-6.48
≥22 8.65 21.33 2.86* 1.59-5.13
≥23 4.81 16.59 3.94* 1.89-8.18
≥24 2.40 9.48 4.25* 1.56-11.55
≥25 1.92 3.79 2.01* 0.60-6.78
≥26 1.92 2.37 1.24* 0.33-4.67
Abbreviations: OR, Odds Ratio; 95% CI, lower and upper 95% confidence
intervall limit; *, significant p-value, i.e. < 0.05.
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fies the risk of hypospadias in Caucasians.Methods
We investigated DNA from 211 cases with hypospadias.
The cases composed of 33 patients with penoscrotal,
scrotal or perineal phenotype, and 178 with glandular,
coronar, mid or distal penil phenotype, as classified by A.
N (pediatric surgeon at Karolinska University Hospital).
The control group consisted of 208 healthy voluntary
anonymous blood sample donors, all males, from the
Karolinska University Hospital. The cases and controls
were of Caucasian origin. Genomic DNA was extracted
from either tissue harvested at surgery or from periph-
eral blood according to standard procedures reported
elsewhere [20]. This study was approved by the Ethics
Committee at Karolinska University Hospital. Informed
written consent was obtained from all participants
involved in the study.
Adamovic and Nordenskjöld BMC Medical Genetics 2012, 13:109 Page 4 of 4
http://www.biomedcentral.com/1471-2350/13/109Tri glutamine-repeats investigation
The CAG repeat region located in the AR gene was PCR
amplified and mixed with 500-Rox size standard, and
electrophoresed on the ABI3730 Sequencer (Applied
Biosystems). Primer and PCR amplification conditions
have been reported previously [13]. In total, 211 hypo-
spadias cases and 208 male controls were investigated. A
difference in the mean CAG repeat length between the
hypospadias and control group was tested using the
T-test for independent groups, since the data was
considered to be normally distributed. Furthermore,
using Chi-Square test we calculated whether a significant
difference in the median length could be detected. In
addition we compared the two groups for a range of
repeat sizes (Odds Ratio and Confidence Interval was
calculated) using logistic regression. The statistical
analysis was implemented using Statistica 10.0, StatSoftW
(Inc. Tulsa OK, USA).
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